Zydus and Astellas patent dispute settlement, Zydus Astellas patent dispute settlement, Zydus patent dispute settlement

Zydus Life and Astellas Patent Dispute Settlement: A $120 Million Resolution

The landscape of pharmaceutical intellectual property is often defined by the rigorous defense of proprietary formulations and the strategic entry of generic alternatives. Recently, a major milestone was reached in this arena as the U.S. unit of Zydus Lifesciences finalized a significant agreement with Astellas Pharma. The Zydus and Astellas Patent Dispute Settlement involves a […]

Natsoft vs Hexaware Patent case, Hexaware patent infringement

US Tech Firm Natsoft Drags Hexaware Into $500M Patent Fight

Hexaware Technologies, a leading Indian IT services company, is facing a massive $500 million lawsuit filed by US-based Natsoft Corporation and its subsidiary Updraft. Natsoft vs Hexaware patent case The case revolves around alleged contract violations and patent infringement, making it one of the biggest intellectual property rights (IPR) disputes in the IT sector. This […]

mRNA TALEN patent infringement case, mRNA technology patent case, Cellectis AstraZeneca patent dispute.

AstraZeneca Faces and Cellectis Inc. Patent Infringement Lawsuit by Factor Bioscience Over mRNA Gene-Editing Tech

A major patent dispute is making headlines in the pharmaceutical world, involving three big names in biotech and drug development.  mRNA TALEN patent infringement case Factor Bioscience Inc., a U.S.-based biotech company, has filed a patent infringement lawsuit against AstraZeneca PLC (a UK-based pharmaceutical giant) and Cellectis Inc. (a French-American biopharmaceutical firm). Factor Bioscience accuses […]